FloBiotech

📍 Basel, Switzerland🗓 Founded 2024👥 7 employees💰 Last funded Mar 2025
Biotechnology Research
LinkedIn
FloBiotech is an early stage biotech company using advanced human brain cell models to develop disease-modifying therapeutic and diagnostic candidates to cure Alzheimer’s disease (AD). Our proprietary cell models (FloCells) will accelerate the search for and creation of effective treatments to transform Alzheimers drug discovery and development (and other Tauopathies). The powerhouse team brought together at FloBiotech has the expertise, the vision, and the revolutionary technology to deliver transformative results and save the lives of the people we love.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in FloBiotech?
FloBiotech has 2 investors on record on gritt.io, including 2 early-stage backers.
When did FloBiotech last raise funding?
The most recent investment in FloBiotech recorded on gritt.io was in March 2025.
When was FloBiotech founded?
FloBiotech was founded in 2024.
What industry is FloBiotech in?
FloBiotech operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is FloBiotech based?
FloBiotech is headquartered in Basel, Switzerland.